Viewing Study NCT01875250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-03-03 @ 7:25 AM
Study NCT ID: NCT01875250
Status: COMPLETED
Last Update Posted: 2020-09-16
First Post: 2013-06-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gene Transfer View
None Androgen Receptor Antagonist View
None PSA View
None Immune Response View
None Immunotherapy View